Trial intelligence / Profile preview

High-Dose Carboplatin with Amifostine and Stem Cell Support in Ovarian Cancer

NCT00003136Phase 2Completed

Sponsor
University of Chicago
Start
Dec 1996
Primary completion
Dec 2000
Modality
DNA Intercalators/Alkylators
Countries
1
01

Overview

A Phase 2 trial of carboplatin in ovarian epithelial cancer, primary peritoneal carcinoma (PPC), sponsored by University of Chicago. Started Dec 1996; status: completed.

02

Drugs

carboplatin
03

Conditions

ovarian epithelial cancerprimary peritoneal carcinoma (PPC)

Beyond the preview

Go deeper on NCT00003136.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00003136.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call